Applications of nanoparticles in the transdermal delivery of chemotherapy against breast cancer: a mini-review
DOI:
https://doi.org/10.60988/p.v37i2S.271Keywords:
application; breast cancer; chemotherapeutics; nanoparticles; transdermalAbstract
Transdermal administration represents a promising drug delivery strategy due to its non-invasive nature and potential for controlled, sustained release. By circumventing hepatic first-pass metabolism, it may reduce the need for excessive dosing and enhance therapeutic efficacy. However, the transdermal delivery of chemotherapeutic agents for breast cancer remains challenging, primarily due to the poor skin permeability of most anticancer drugs, which typically exhibit high molecular weight and limited lipid solubility. This mini-review critically examines recent advances in nanoparticle-based systems designed to facilitate transdermal chemotherapy for breast cancer. We categorize the types of nanoparticles employed, discuss their mechanisms of action and therapeutic advantages, and outline future directions for research and clinical translation.
References
1. Fareed N.Y., Kassab H.J. Diacerein loaded novasome for transdermal delivery: preparation, in vitro characterization and factors affecting formulation. Iraqi J. Pharm. Sci. 32(s), 214–224, 2023. DOI: 10.31351/vol32isssuppl.pp214-224
2. Salih O.S., Al-Akkam E.J. Preparation, in vitro, and ex vivo evaluation of ondansetron loaded invasomes for transdermal delivery. Iraqi J. Pharm. Sci. 32(3), 71–84, 2023. DOI: 10.31351/vol32iss3pp71-84
3. Mukherjee D., Raikwar S. Recent update on nanocarrier(s) as the targeted therapy for breast cancer. AAPS PharmSciTech 25(6), 153, 2024. DOI: 10.1208/s12249-024-02867-x
4. Khan S.U., Ullah M., Saeed S., Saleh E.A.M., Kassem A.F., Arbi F.M., et al. Nanotherapeutic approaches for transdermal drug delivery systems and their biomedical applications. Eur. Polym. J. 207, 112819, 2024. DOI: 10.1016/j.eurpolymj.2024.112819
5. Mekkawy A.I., Eleraky N.E., Soliman G.M., Elnaggar M.G., Elnaggar M.G. Combinatorial therapy of letrozole- and quercetin-loaded spanlastics for enhanced cytotoxicity against MCF-7 breast cancer cells. Pharmaceutics 14(8), 1727, 2022. DOI: 10.3390/pharmaceutics14081727
6. Jiang T., Xu G., Chen G., Zheng Y. He B., Gu Z. Progress in transdermal drug delivery systems for cancer therapy. Nano Res. 13, 1810–1824, 2020. DOI: 10.1007/s12274-020-2664-5
7. Sani A., Pourmadadi M., Shaghaghi M., Eshaghi M.M., Shahmollaghamsary S., Arshad R., et al. Revolutionizing anticancer drug delivery: exploring the potential of tamoxifen-loaded nanoformulations. J. Drug Deliv. Sci. Technol. 86, 104642, 2023. DOI: 10.1016/j.jddst.2023.104642
8. Dongsar T.T., Dongsar T.S., Gupta N., Almalki W.H., Sahebkar A., Kesharwani P. Emerging potential of 5-fluorouracil-loaded chitosan nanoparticles in cancer therapy. J. Drug Deliv. Sci. Technol. 82, 104371, 2023. DOI: 10.1016/j.jddst.2023.104371
9. Altameemi K.K.A., Abd-Alhammid S.N. Anastrozole nanoparticles for transdermal delivery through microneedles: preparation and evaluation. J. Pharm. Negat. Results 13(3), 974–980, 2022. DOI: 10.47750/pnr.2022.13.03.152
10. Mukhtar M., Ezra Manicum A.L., Shojaei Barjouei M., Eshaghi Malekshah R., Behzadmehr R., Rahdar A., et al. Nanocarriers for methotrexate delivery/codelivery in the frame of cancer diagnostics and treatment: a review. Front. Biomater. Sci. 2, 1200670, 2023. DOI: 10.3389/fbiom.2023.1200670
